Get the Stockscreener App
2.60
12.07%
0.28
Pre-market:
2.69
0.09
+3.46%
Nrx Pharmaceuticals Inc stock is traded at $2.60, with a volume of 643.08K.
It is up +12.07% in the last 24 hours and up +0.39% over the past month.
NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.
See More
Previous Close:
$2.32
Open:
$2.28
24h Volume:
643.08K
Relative Volume:
2.12
Market Cap:
$51.51M
Revenue:
-
Net Income/Loss:
$-30.15M
P/E Ratio:
-0.65
EPS:
-4
Net Cash Flow:
$-21.66M
1W Performance:
-1.14%
1M Performance:
+0.39%
6M Performance:
+14.54%
1Y Performance:
+39.04%
1-Day Range:
$2.28
$2.73
1-Week Range:
$2.26
$2.81
52-Week Range:
$1.10
$6.01
Nrx Pharmaceuticals Inc Stock (NRXP) Company Profile
Name
Nrx Pharmaceuticals Inc
Sector
Industry
Phone
484-254-6134
Address
1201 ORANGE STREET, WILMINGTON
Compare NRXP with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NRXP
Nrx Pharmaceuticals Inc
|
2.60 | 55.15M | 0 | -30.15M | -21.66M | -4.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
401.00 | 100.25B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
577.90 | 61.55B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
447.00 | 58.53B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
706.41 | 43.59B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
332.04 | 33.67B | 3.81B | -644.79M | -669.77M | -6.24 |
Nrx Pharmaceuticals Inc Stock (NRXP) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-02-25 | Initiated | BTIG Research | Buy |
Nrx Pharmaceuticals Inc Stock (NRXP) Latest News
Is NRx Pharmaceuticals Inc. Equity Warrant trending in predictive chart modelsTrade Entry Summary & Precise Buy Zone Identification - Newser
What earnings revisions data tells us about NRx Pharmaceuticals Inc.Sell Signal & Capital Efficiency Focused Ideas - Newser
Is a relief rally coming for NRx Pharmaceuticals Inc. holdersGold Moves & Breakout Confirmation Trade Signals - Newser
Using Ichimoku Cloud for NRx Pharmaceuticals Inc. Equity Warrant technicalsWeekly Gains Report & Real-Time Volume Analysis - Newser
How sentiment analysis helps forecast NRx Pharmaceuticals Inc. Equity WarrantJobs Report & Verified Chart Pattern Signals - Newser
Sentiment analysis tools applied to NRx Pharmaceuticals Inc.2025 Price Momentum & Breakout Confirmation Alerts - Newser
Signal strength of NRx Pharmaceuticals Inc. Equity Warrant stock in tech scanners2025 Top Decliners & Daily Risk Controlled Trade Plans - Newser
Why NRx Pharmaceuticals Inc. is moving todayJuly 2025 Drop Watch & Long-Term Safe Return Strategies - Newser
Published on: 2025-09-02 23:18:18 - Newser
What high frequency data says about NRx Pharmaceuticals Inc. Equity WarrantPortfolio Risk Report & High Return Trade Opportunity Guides - Newser
Is NRx Pharmaceuticals Inc. Equity Warrant likely to announce a buybackJuly 2025 Decliners & Fast Moving Stock Watchlists - خودرو بانک
What’s next for NRx Pharmaceuticals Inc. Equity Warrant stock priceJuly 2025 Outlook & Reliable Intraday Trade Plans - Newser
Analyzing NRx Pharmaceuticals Inc. with multi timeframe chartsWeekly Market Outlook & Weekly High Return Stock Forecasts - Newser
Should you avoid NRx Pharmaceuticals Inc. Equity Warrant stock right nowMarket Rally & Technical Analysis for Trade Confirmation - خودرو بانک
What institutional flow reveals about NRx Pharmaceuticals Inc. Equity WarrantFed Meeting & Low Drawdown Trading Strategies - Newser
NRx Pharmaceuticals Inc.’s volatility index tracking explainedTrade Analysis Summary & Free Technical Pattern Based Buy Signals - Newser
Can technical indicators confirm NRx Pharmaceuticals Inc.’s reversalDay Trade & Real-Time Market Trend Scan - Newser
UPDATE -- NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Selected - GlobeNewswire
How hedge fund analytics apply to NRx Pharmaceuticals Inc. stock2025 Major Catalysts & High Yield Equity Trading Tips - Newser
90% Treatment Response Target: NRx's HOPE Clinics to Revolutionize Depression & PTSD Care with Triple Therapy - Stock Titan
How high can NRx Pharmaceuticals Inc. Equity Warrant stock goPortfolio Performance Summary & AI Forecasted Entry/Exit Points - Newser
NRx Pharmaceuticals Inc. stock momentum explainedJuly 2025 Market Mood & AI Forecasted Stock Moves - Newser
Momentum divergence signals in NRx Pharmaceuticals Inc. Equity Warrant chartJuly 2025 Earnings & Fast Entry and Exit Trade Plans - Newser
How to use Fibonacci retracement on NRx Pharmaceuticals Inc.Weekly Stock Analysis & Short-Term High Return Ideas - Newser
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Selected to Present at the 2025 Global Passion Project with Matthew Rockefeller and Rockefeller Capital - The Globe and Mail
NRx Pharmaceuticals Presents HOPE Therapeutics Rollout Plans, Raises $8.8M. - AInvest
NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Selected to Present - GlobeNewswire
90% Treatment Response Target: NRx Pharma's Revolutionary Mental Health Centers Combine Three Therapies - Stock Titan
Published on: 2025-09-02 15:20:07 - خودرو بانک
NRx Pharmaceuticals and the Fast-Tracking of Ketamine-Based Therapies for Suicidal Depression: A High-Impact Investment Opportunity - AInvest
NRx Pharmaceuticals, Inc. (NRXP)’ NRX-100 Wins Expanded FDA Fast Track for Suicidal Depression - MSN
Can NRx Pharmaceuticals Inc. lead its sector in growthMarket Sentiment Report & Smart Investment Allocation Insights - خودرو بانک
How to read the order book for NRx Pharmaceuticals Inc.Rate Cut & Community Trade Idea Sharing - Newser
Order flow analysis tools used on NRx Pharmaceuticals Inc. Equity Warrant2025 Sector Review & Low Risk High Reward Ideas - Newser
Can trapped investors hope for a rebound in NRx Pharmaceuticals Inc.July 2025 PostEarnings & Free Weekly Chart Analysis and Trade Guides - Newser
Evaluating NRx Pharmaceuticals Inc. with trendline analysisEarnings Growth Report & Community Verified Swing Trade Signals - Newser
Aug Setups: What is NRx Pharmaceuticals Inc. Equity Warrant’s valuation compared to sectorGap Up & Safe Swing Trade Setup Alerts - خودرو بانک
Published on: 2025-09-02 02:27:59 - خودرو بانک
What recovery options are there for NRx Pharmaceuticals Inc. Equity WarrantBreakout Watch & Risk Controlled Stock Pick Alerts - Newser
Does NRx Pharmaceuticals Inc. have a sustainable dividendJuly 2025 EndofMonth & Capital Efficient Trade Techniques - خودرو بانک
Identifying reversal signals in NRx Pharmaceuticals Inc.July 2025 Spike Watch & High Return Trade Opportunity Guides - Newser
Is NRx Pharmaceuticals Inc. Equity Warrant stock risky to hold nowWeekly Trade Analysis & Long Hold Capital Preservation Tips - خودرو بانک
Should you wait for a breakout in NRx Pharmaceuticals Inc. Equity Warrant2025 Price Momentum & AI Enhanced Trading Signals - Newser
Will NRx Pharmaceuticals Inc. Equity Warrant Reverse From Oversold Conditions2025 Support & Resistance & Stock Portfolio Risk Management - beatles.ru
NRx Pharmaceuticals Inc. stock trend outlook and recovery pathQuarterly Profit Report & Real-Time Buy Signal Notifications - Newser
NRx Pharmaceuticals' Q2 Earnings Call Highlights Strategic Progress, Financial Improvements, and Regulatory Challenges. - AInvest
NRx Pharmaceuticals’ Earnings Call Highlights Strategic Progress - TipRanks
Real time alert setup for NRx Pharmaceuticals Inc. Equity Warrant performancePrice Action & Reliable Entry Point Trade Alerts - Newser
News impact scoring models applied to NRx Pharmaceuticals Inc.Trade Analysis Summary & Technical Confirmation Trade Alerts - Newser
Published on: 2025-08-31 19:20:04 - Newser
Can a trend reversal in NRx Pharmaceuticals Inc. lead to recovery2025 Key Lessons & Weekly Top Gainers Alerts - Newser
Nrx Pharmaceuticals Inc Stock (NRXP) Financials Data
Revenue
Net Income
Cash Flow
EPS
4.10%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):